Opendata, web and dolomites

EQUIVert SIGNED

Worldwide unique biofeedback system for non-invasive vertigo therapy and fall prevention

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EQUIVert project word cloud

Explore the words cloud of the EQUIVert project. It provides you a very rough idea of what is the project "EQUIVert" about.

sensory    2024    anywhere    introduction    symptom    adapts    everyday    parallel    effectiveness    private    acoustic    vertigo    combination    options    trainer    employees    huge    professional    shortly    patients    impossible    organ    anytime    benefits    accumulated    individual    total    disturbance    central    until    sound    provides    least    life    ultimately    30    medical    complete    unfortunately    purchase    hard    personal    guide    exercises    headphone    price    unconscious    physicians    dizziness    diagnosis    treatment    training    possibility    position    audio    sensitivity    overcome    once    human    otherwise    train    right    device    preinstalled    inner    registration    shortcomings    causing    equivert    market    dynamically    wrong    progress    caused    give    form    lifetime    healthcare    brain    initially    foreseen    22    conscious    ged    properly    ease    ear    severe    compensate    gesture    worldwide    ready    followed    16    sensor    biofeedback    home    eur    time    people    turnover    medicine    planning    regarding    balance    ongoing    million    expansion   

Project "EQUIVert" data sheet

The following table provides information about the project.

Coordinator
GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH 

Organization address
address: PASTORATSSTRASSE 3
city: RUPPICHTEROTH
postcode: 53809
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GED GESELLSCHAFT FUR ELEKTRONIK UNDDESIGN MBH DE (RUPPICHTEROTH) coordinator 50˙000.00

Map

 Project objective

Vertigo (dizziness) is the second most common symptom in medicine, causing 30% of all people worldwide to be treated at least once in their lifetime. It is caused by a disturbance of the balance organ in our inner ear and has a significant impact on our everyday life, making many activities very hard or even impossible. However, through effective balance training, the human brain is capable to compensate for the wrong sensory information and can ultimately overcome vertigo. Unfortunately, current treatment options show severe shortcomings regarding costs, availability, and effectiveness of training. To overcome this problem, GED has developed EQUIVert. EQUIVert is the personal balance trainer for the home and professional use. It is a headphone with integrated position sensor and gesture control. It provides real-time acoustic biofeedback through sound to give the user conscious access to the otherwise unconscious combination of balance and depth sensitivity. EQUIVert is a complete system and ready to use. All exercises and training programmes are already preinstalled in the audio guide and it dynamically adapts the exercises to training progress and individual form. The major benefits for the users are the low purchase price, the effectiveness of the training, the ease of use, and the possibility to train anytime and anywhere. With over 100 million potential patients in Europe and the US, of which most are not or not properly treated right now, EQUIVert has a huge market creating potential. GED is planning a parallel market introduction, addressing private patients with an individual training device and healthcare physicians with a diagnosis support device. Following the already ongoing registration as medical device, EQUIVert will initially be introduced into the Central European market, shortly followed by an expansion across Europe and the US. A total of 22 new employees and an accumulated turnover of EUR 16 million is foreseen until the end of 2024.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EQUIVERT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EQUIVERT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More